NO982582D0 - Procedure for treating pain - Google Patents

Procedure for treating pain

Info

Publication number
NO982582D0
NO982582D0 NO982582A NO982582A NO982582D0 NO 982582 D0 NO982582 D0 NO 982582D0 NO 982582 A NO982582 A NO 982582A NO 982582 A NO982582 A NO 982582A NO 982582 D0 NO982582 D0 NO 982582D0
Authority
NO
Norway
Prior art keywords
procedure
treating pain
pain
treating
Prior art date
Application number
NO982582A
Other languages
Norwegian (no)
Other versions
NO982582L (en
Inventor
Charles H Mitch
Harlan E Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO982582D0 publication Critical patent/NO982582D0/en
Publication of NO982582L publication Critical patent/NO982582L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO982582A 1995-12-07 1998-06-05 Procedure for the treatment of pain NO982582L (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US831895P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US829895P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US829595P 1995-12-07 1995-12-07
US830695P 1995-12-07 1995-12-07
PCT/US1996/019390 WO1997020556A1 (en) 1995-12-07 1996-12-05 Method for treating pain

Publications (2)

Publication Number Publication Date
NO982582D0 true NO982582D0 (en) 1998-06-05
NO982582L NO982582L (en) 1998-08-03

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982582A NO982582L (en) 1995-12-07 1998-06-05 Procedure for the treatment of pain

Country Status (14)

Country Link
EP (1) EP0866702A4 (en)
JP (1) JP2000501711A (en)
KR (1) KR19990071977A (en)
CN (1) CN1208348A (en)
AU (1) AU715645B2 (en)
CA (1) CA2239732A1 (en)
CZ (1) CZ174598A3 (en)
EA (1) EA199800535A1 (en)
HU (1) HUP0000110A3 (en)
IL (1) IL124786A0 (en)
NO (1) NO982582L (en)
NZ (1) NZ324594A (en)
PL (1) PL327144A1 (en)
WO (1) WO1997020556A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60004835T2 (en) 1999-06-04 2004-06-09 Eli Lilly And Co., Indianapolis 7-oxo-2-azabicyclo [2.2.1] heptanes as a selective muscarinic receptor antagonist
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
JP2017531026A (en) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド Sustained release abuse deterrent liquid filler form
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
WO2023061372A1 (en) * 2021-10-14 2023-04-20 南京迈诺威医药科技有限公司 Malate salt of xanomeline derivative, crystalline form a, and preparation method therefor and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DK198590D0 (en) * 1990-08-21 1990-08-21 Novo Nordisk As HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Also Published As

Publication number Publication date
WO1997020556A1 (en) 1997-06-12
CA2239732A1 (en) 1997-06-12
CZ174598A3 (en) 1999-01-13
JP2000501711A (en) 2000-02-15
EA199800535A1 (en) 1998-12-24
EP0866702A1 (en) 1998-09-30
NZ324594A (en) 1999-09-29
EP0866702A4 (en) 2001-07-25
NO982582L (en) 1998-08-03
HUP0000110A2 (en) 2000-06-28
AU1147697A (en) 1997-06-27
KR19990071977A (en) 1999-09-27
AU715645B2 (en) 2000-02-10
IL124786A0 (en) 1999-01-26
CN1208348A (en) 1999-02-17
PL327144A1 (en) 1998-11-23
HUP0000110A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
NO984431D0 (en) Procedure for treating pain
NO982172D0 (en) Use of epinastine for the treatment of pain
NO976063D0 (en) Procedure for the treatment of diabetes
NO991955L (en) Process for the treatment of hydrocarbons
DE69618176T2 (en) SOFT TREATED TISSUE
PT777975E (en) VEGETABLE TREATMENT
DE69609959D1 (en) EXHAUST TREATMENT
DE19681419T1 (en) Treatment system
GB9519033D0 (en) Treatment
NO984446D0 (en) Procedure for treating pain
NO982911D0 (en) Procedure for treating depression
NO983263L (en) Distributed treatment
IS4789A (en) treatment Compounds
NO982582D0 (en) Procedure for treating pain
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO982562D0 (en) Composition for the treatment of pain
BR9610382A (en) Cableo treatment composition
DE59607418D1 (en) HAIR TREATMENT
ID16924A (en) POLYLELEFIN TREATMENT METHOD
DE69614077T2 (en) Heat treatment plant
DE29508067U1 (en) Facility for physiotherapy treatment
DE29513387U1 (en) Treatment couch
DE19680740T1 (en) Fiber treatment composition
KR960028346U (en) Moxa
DE29516192U1 (en) Treatment couch